The American Brachytherapy Society was founded in 1978 to provide insight, rationale, and research into the use of brachytherapy in the treatment of both malignant and benign conditions. The organization consists of physicians, physicists, nurses, radiation therapists, trainees in various disciplines and others interested in brachytherapy.
Brachytherapy is used primarily to treat prostate, breast, and cervical cancers and for variety of other cancers including, lung, esophagus, skin cancer, sarcoma, rectum, penis, and ocular melanoma. Because it is much less invasive than surgery, and less disruptive to the patients, brachytherapy offers an effective and meaningful alternative for organ preservation (for example, penis cancer, ocular melanoma, and prostate or rectum cancer). Brachytherapy is an integral part of successful treatment for cervical cancer. When used as a component of treatment, brachytherapy improves survival in patients with advanced disease over the external beam radiating alone. Brachytherapy for prostate cancer improves disease outcomes over external beam radiation, and is a most cost effective treatment for prostate cancer. The American Cancer Society estimates that there will be:
Please select from the following: